Octapeptide antagonists of angiotensin II are more potent inhibitors of aldosterone production than heptapeptide antagonists in rat adrenal cells, suggesting conversion to des-Asp1Ang II is not required for steroidogenesis.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating in rat adrenal cells; human relevance of octapeptide Ang II antagonists remains untested.
With a view to determine whether octapeptide or heptapeptide antagonists of angiotensin II (Ang II) preferentially inhibit steroidogenesis induced by Ang II, we have compared five heptapeptide antagonists with the corresponding octapeptide antagonists. Each octapeptide antagonist had sarcosine in the 1-position and various substituents in the 8-position [e.g. He, Ala, Thr, Thr(Me), or Ser], and there was a corresponding heptapeptide antagonist with the same substituent in the 7-position. These studies used rat adrenal glomerulosa cells prepared with the aid of collagenase and mechanical dispersion. Only a few of the five pairs of antagonists exhibited significant agonist activity. These were Ile8 and Ala8 pairs of antagonists. The octapeptides proved to be better antagonists in inhibiting Ang II-induced aldosterone production than any of the corresponding heptapeptide antagonists. This was consistent with the previous observation that the octapeptide antagonists were more potent inhibitors of Ang II receptor binding in the adrenal. The order of potency of the octapeptide antagonists as inhibitors of Ang II-induced aldosterone production was [Sar1, He8]Ang II > [Sar1, Thr8]Ang II > [Sar1, Thr(Me)8]Ang II > [Sar1, Ala8]Ang II > [Sar1, Ser8]Ang II. This order of potency was significantly correlated with their order of potency as inhibitors of Ang II receptor binding (r = 0.78; P < 0.005). The inhibition of Ang IIinduced aldosterone production by the octapeptide antagonists fits the definition of true competitive antagonism, as analyzed with double reciprocal plots of Lineweaver-Burk. Among the heptapeptide antagonists, des-Asp1[Ala8]Ang II and des-Asp1[Ile8]Ang II were the best inhibitors of Ang IIinduced steroidogenesis, consistent with the previous observation that they had the highest receptor-binding affinity among the heptapeptide antagonists. The usefulness of the heptapeptide antagonist was limited, in that at low concentrations it frequently potentiated rather than inhibited Ang II-induced aldosterone secretion. Octapeptide antagonists proved, as a group, to be better inhibitors of Ang II-induced aldosterone production than heptapeptide antagonists, consistent with their greater potency as inhibitors of Ang II receptor binding to the adrenal glomerulosa. Therefore, these studies further emphasize that conversion of Ang II to des-Asp1Ang II is not an obligatory step in Ang IIinduced steroidogenesis in the rat adrenal.
No takes yet. Share an insight, caveat, or question.
Douglas et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: